Jacqueline Watchmaker is a Dermatology physician. OpenAlex indexes 44 publications with 234 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
10900 N Scottsdale Rd
Scottsdale, AZ 852545216
Telephone
480-210-1988Provider last certified this registry record 31 Aug 2021.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202562 payments$30,747openpaymentsdata.cms.gov ↗
- Botanix SB IncProgram year20252 payments
- Verrica Pharmaceuticals Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor24.8%Valacyclovir100%Part D≥40 patientsAzole Antifungal10.6%Ketoconazole100%Part D<11 patients+ 1 more class in this area
Dermatology
33.9%Corticosteroid33.9%Triamcinolone Acetonide51%Triamcinolone acetonide34%Methylprednisolone15%Part D + Part B≥35 patientsCancer & immunology
9.6%Nucleoside Metabolic Inhibitor9.6%Fluorouracil100%Part D≥21 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Randomized, Double-blind, Split-face Trial Evaluating the Safety and Efficacy of a Serum Containing Plant Adaptogens Versus Moisturizing Lotion Pre- and Post-fractional Laser in Patients with Mild-to-moderate Photodamage.
PubMed
2026 - A Multicenter Trial Evaluating the Safety and Efficacy of a Serum Containing Plant Adaptogens in Patients With Mild-to-Moderate, Persistent Centrofacial Erythema Associated With Rosacea.
PubMed
2026 - The History and Advancement of Light, Lasers, and Energy-Based Devices in Dermatologic Surgery
Dermatologic Surgery
2025 - Reversing Glycation with a Dietary Supplement Containing Rosemary Extract.
PubMed
2025 - A Multi-center Trial Evaluating a Serum Comprised of Plant-based Adaptogens Targeting Skin Quality.
PubMed
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”